NCT01505881 - Follow on Study From RE-ALIGN | Biotech Hunter

Enrollment

158

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions

ThromboembolismHeart Valve Prosthesis

Interventions

DRUG

dabigatran etexilate low dose

active treatment (low)

DRUG

warfarin 5mg

comparator warfarin

DRUG

dabigatran etexilate intermediate dose

active treatment (medium)

DRUG

warfarin 1mg

comparator warfarin

DRUG

dabigatran etexilate high dose

active treatment (high)

DRUG

warfarin 3mg

comparator warfarin

Trial Locations (30)

Unknown

1160.138.32003 Boehringer Ingelheim Investigational Site, Brussels

1160.138.32002 Boehringer Ingelheim Investigational Site, Genk

1160.138.32001 Boehringer Ingelheim Investigational Site, Leuven

1160.138.11001 Boehringer Ingelheim Investigational Site, Saint John

1160.138.11009 Boehringer Ingelheim Investigational Site, Hamilton

1160.138.11011 Boehringer Ingelheim Investigational Site, London

1160.138.11012 Boehringer Ingelheim Investigational Site, Newmarket

1160.138.11007 Boehringer Ingelheim Investigational Site, Toronto

1160.138.42002 Boehringer Ingelheim Investigational Site, Brno

1160.138.42003 Boehringer Ingelheim Investigational Site, Olomouc

1160.138.42004 Boehringer Ingelheim Investigational Site, Ostrava

1160.138.42001 Boehringer Ingelheim Investigational Site, Prague

1160.138.45001 Boehringer Ingelheim Investigational Site, Copenhagen

1160.138.45002 Boehringer Ingelheim Investigational Site, Odense C

1160.138.33004 Boehringer Ingelheim Investigational Site, Bron

1160.138.33001 Boehringer Ingelheim Investigational Site, Paris

1160.138.33002 Boehringer Ingelheim Investigational Site, Pessac

1160.138.33003 Boehringer Ingelheim Investigational Site, Rennes

1160.138.49001 Boehringer Ingelheim Investigational Site, Dresden

1160.138.49002 Boehringer Ingelheim Investigational Site, Essen

1160.138.49004 Boehringer Ingelheim Investigational Site, Freiburg im Breisgau

1160.138.49003 Boehringer Ingelheim Investigational Site, Heidelberg

1160.138.49010 Boehringer Ingelheim Investigational Site, Witten

1160.138.31002 Boehringer Ingelheim Investigational Site, Amsterdam

1160.138.31004 Boehringer Ingelheim Investigational Site, Breda

1160.138.47002 Boehringer Ingelheim Investigational Site, Bergen

1160.138.47001 Boehringer Ingelheim Investigational Site, Oslo

1160.138.48004 Boehringer Ingelheim Investigational Site, Gdansk

1160.138.48003 Boehringer Ingelheim Investigational Site, Warsaw

1160.138.48001 Boehringer Ingelheim Investigational Site, Wroclaw